Therapeutic potential of Artemisia vulgaris: An insight into underlying immunological mechanisms.


Journal

Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer
ISSN: 2162-6537
Titre abrégé: J Environ Pathol Toxicol Oncol
Pays: United States
ID NLM: 8501420

Informations de publication

Date de publication:
2019
Historique:
entrez: 4 11 2019
pubmed: 5 11 2019
medline: 8 11 2019
Statut: ppublish

Résumé

Artemisia vulgaris is a traditional Chinese herb believed to have a wide range of healing properties; it is traditionally used to treat numerous health ailments. The plant is commonly called mugwort or riverside wormwood. The plant is edible, and in addition to its medicinal properties, it is also used as a culinary herb in Asian cooking in the form of a vegetable or in soup. The plant has garnered the attention of researchers in the past few decades, and several research studies have investigated its biological effects, including antioxidant, anti-inflammatory, anticancer, hypolipidemic, and antimicrobial properties. In this review, various studies on these biological effects are discussed along with the tests conducted, compounds involved, and proposed mechanisms of action. This review will be of interest to the researchers working in the field of herbal medicine, pharmacology, medical sciences, and immunology.

Identifiants

pubmed: 31679308
pii: 3315952e49b02c32,0cf9a7c6585db3c5
doi: 10.1615/JEnvironPatholToxicolOncol.2019029397
doi:

Substances chimiques

Anti-Infective Agents 0
Anti-Inflammatory Agents 0
Antineoplastic Agents 0
Antioxidants 0
Hypolipidemic Agents 0
Plant Extracts 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

205-216

Auteurs

Laura Soon (L)

School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia.

Phui Qi Ng (PQ)

School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia.

Jestin Chellian (J)

Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia.

Thiagarajan Madheswaran (T)

Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia.

Jithendra Panneerselvam (J)

Department of Pharmaceutical Technology, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia.

Gaurav Gupta (G)

Suresh Gyan Vihar University.

Srinivas Nammi (S)

School of Science and Health, Western Sydney University, NSW, 2751, Australia; NICM Health Research Institute, Western Sydney University, NSW, 2751, Australia.

Nicole G Hansbro (NG)

Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, NSW 2308, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia; Faculty of Science, University of Technology Sydney, Ultimo NSW 2007, Australia.

Alan Hsu (A)

Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, NSW 2308, Australia.

Harish Dureja (H)

Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, Haryana 124001, India.

Meenu Mehta (M)

School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara-144411, Punjab, India.

Saurabh Satija (S)

School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road (NH-1), Phagwara-144411, Punjab, India.

Philip M Hansbro (PM)

Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, NSW 2308, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia; Faculty of Science, University of Technology Sydney, Ultimo NSW 2007, Australia.

Kamal Dua (K)

Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) and School of Biomedical Sciences and Pharmacy, The University of Newcastle (UoN), Callaghan, NSW 2308, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia; Faculty of Science, University of Technology Sydney, Ultimo NSW 2007, Australia.

Trudi Collet (T)

Indigenous Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Kelvin Grove, Brisbane, Queensland 4059, Australia.

Dinesh Kumar Chellappan (DK)

Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged
Fragaria Light Plant Leaves Osmosis Stress, Physiological
Humans Female Alopecia Breast Neoplasms Middle Aged

Classifications MeSH